Mein Warenkorb

Plate

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
BNZ-1BNZ132-1-40; BNZ-1; BNZ132-1; BNZ-01; EQ101; EQ-101Phase 2 ClinicalBioniz Therapeutics IncAlopecia; Alopecia Areata; Lymphoma, T-Cell, Cutaneous; Leukemia, Large Granular Lymphocytic
Details
OrdesekimabHuMab-IL15; AMG-714; PRV-015Phase 2 ClinicalProvention Bio Inc, Genmab A/S, Amgen IncArthritis, Rheumatoid; Celiac Disease; Psoriasis; Lymphoma, T-Cell; Vitiligo
Details
HCW-9218HCW-9218Phase 2 ClinicalHCW Biologics IncOvarian Neoplasms; Solid tumours; Pancreatic Neoplasms; Pulmonary Fibrosis
Details
NY-ESO-1 TCR/IL-15 NKPhase 2 ClinicalThe University Of Texas MD Anderson Cancer Center, Syena, Replay Holdings LLCSarcoma, Synovial; Multiple Myeloma; Liposarcoma, Myxoid
Details
IL15-transpresenting WT1-targeted Dendritic Cell Vaccine(Antwerp University Hospital)Phase 2 ClinicalAntwerp University HospitalLiver Neoplasms; Ovarian Neoplasms; Esophageal Neoplasms; Pancreatic Neoplasms
Details
CAR-5/IL-15-transduced CB-NK cell therapyPhase 2 ClinicalThe University Of Texas MD Anderson Cancer CenterHematologic Neoplasms
Details
Recombinant Human IL12/15-PDL1B Herpes Simplex Type I Oncolytic Virus (Cnbg-Virogin Biotech (Shanghai) Ltd)VG-161Phase 2 ClinicalCnbg-Virogin Biotech (Shanghai) LtdSolid tumours; Biliary Tract Neoplasms; Liver Neoplasms; Esophageal Neoplasms; Stomach Neoplasms; Neoplasms; Pancreatic Neoplasms; Cholangiocarcinoma; Sarcoma; Carcinoma, Hepatocellular
Details
XmAb24306XmAb-24306; RG-6323; RO-7310729; XmAb-306Phase 1 ClinicalGenentech Inc, Xencor IncSolid tumours; Multiple Myeloma
Details
SIM-0237SIM-0237Phase 1 ClinicalSimcere Pharmaceutical Group LtdSolid tumours; Urinary Bladder Neoplasms
Details
CYTO-102CYTO-NK-102; CYTO-102; COH06Phase 1 ClinicalCytoImmune Therapeutics IncLung Neoplasms; Carcinoma, Non-Small-Cell Lung
Details
VG-201VG-201Phase 1 ClinicalViroGin Biotech LtdSolid tumours; Stomach Neoplasms; Esophageal Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung
Details
VG-203VG-203; VG2062; VG-2062Phase 1 ClinicalViroGin Biotech Ltd, Shanghai Funuojian Biotechnology Co Ltd, Virogin Biotech (Shenzhen) Ltd, Fenojian Biotechnology (Nantong) Co LtdOvarian Neoplasms; Solid tumours; Carcinoma, Renal Cell; Breast Neoplasms
Details
ACTM-838ACTM838Phase 1 ClinicalActym Therapeutics IncSolid tumours
Details
CALY-002CALY-002Phase 1 ClinicalIdd BiotechEosinophilic Esophagitis; Celiac Disease
Details
  • Produktliste
  • Klinische Arzneimittelinformation
Kontaktieren Sie uns